| Ürün Adı |
BUPRENORFIN B-D-GLUKURONID |
| Eş anlamlı |
(57-17-(Siklopropilmetil)-4,5-epoksi-18,19-dihidro-7-[(1S)-1-hidroksi-1,2,2,-trimetilpropil]-6-metoksi-6,14-etenomorfinan-3-il b-D-Glukuronid; buprenorfin-3-O-glukuronid; (5,7)-17-(Siklopropilmetil)-4,5-epoksi-18,19-dihidro-7-[(1S)-1-hidroksi-1,2,2,-trimetilpropil]-6-metoksi-6,14-etenomorfinan-3-il-D-Glukuronid; Buprenorfin -D-Glukuronid; (5alfa, 6beta, 14beta, 18R) -17- (siklopropilmetil) -18 - [(2S) -2-hidroksi-3,3-dimetilbütan-2-il] -6-metoksi-18,19-dihidro-4,5-epoksi-6,14-etenomorfinan-2-il beta-D-glukopiranosiduronik asit;
|
| ingilizce adı |
BUPRENORPHINE B-D-GLUCURONIDE;(57-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2,-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-yl b-D-Glucuronide; buprenorphine-3-O-glucuronide; (5,7)-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2,-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-yl -D-Glucuronide; Buprenorphine -D-Glucuronide; (5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-2-yl beta-D-glucopyranosiduronic acid |
| Moleküler Formülü |
C35H49NO10 |
| Molekül Ağırlığı |
643.7643 |
| InChI |
InChI=1/C35H49NO10/c1-31(2,3)32(4,42)21-15-33-8-9-35(21,43-5)30-34(33)10-11-36(16-17-6-7-17)22(33)13-18-12-19(14-20(45-30)23(18)34)44-29-26(39)24(37)25(38)27(46-29)28(40)41/h12,14,17,21-22,24-27,29-30,37-39,42H,6-11,13,15-16H2,1-5H3,(H,40,41)/t21-,22-,24+,25+,26-,27+,29-,30-,32+,33-,34+,35-/m1/s1 |
| CAS kayıt numarası |
101224-22-0 |
| Moleküler Yapısı |
|
| Yoğunluk |
1.43g/cm3 |
| Kırılma indisi |
1.657 |
| Tehlike Sembolleri |
|
| Risk Kodları |
|
| Güvenlik Açıklaması |
|
|
